Bristol-Myers Squibb Co. (BMY) Tops Q1 EPS by 3c; Boosts FY14 Profit Outlook

Bristol-Myers Squibb Co. (NYSE: BMY) reported Q1 EPS of $0.46, $0.03 better than the analyst estimate of $0.43. Revenue for the quarter came in at $3.81 billion versus the consensus estimate of $3.89 billion.

Bristol-Myers Squibb Co. sees FY2014 EPS of $1.70-$1.80, versus prior guidance of $1.65-$1.80 and the consensus of $1.78. Sees worldwide revenues between $15.2 billion and $15.8 billion.

For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c